...
首页> 外文期刊>Human and Experimental Toxicology >Effect of riluzole on Ca2+ movement and cytotoxicity in Madin-Darby canine kidney cells.
【24h】

Effect of riluzole on Ca2+ movement and cytotoxicity in Madin-Darby canine kidney cells.

机译:利鲁唑对Madin-Darby犬肾细胞中Ca2 +运动和细胞毒性的影响。

获取原文
获取原文并翻译 | 示例

摘要

Riluzole is a drug used in the treatment of amyotrophic lateral sclerosis; however, its in vitro action is unclear. In this study, the effect of riluzole on intracellular Ca2+ concentration ([Ca2+]i) in Madin-Darby canine kidney (MDCK) cells was investigated using the Ca2+ -sensitive fluorescent dye, fura-2. Riluzole (100-500 microM) caused a rapid and sustained increase of [Ca2+]i in a concentration-dependent manner (EC50 = 150 microM). Some 40 and 50% of this [Ca2+]i increase was prevented by the removal of extracellular Ca2+ and the addition of La3+, respectively, but was unchanged by dihydropyridines, verapamil and diltiazem. In Ca2+ -free medium, thapsigargin - an inhibitor of the endoplasmic reticulum (ER) Caz+ -ATPase--caused a monophasic [Ca2+]i increase, after which the increasing effect of riluzole on [Ca2+]i was attenuated by 70%; in addition, pre-treatment with riluzole abolished thapsigargin-induced [Ca2+]i increases. U73122, an inhibitor of phospholipase C (PLC), abolished ATP (but not riluzole)-induced [Ca2+]i increases. At concentrations of 250 and 500 microM, riluzole killed 40 and 95% cells, respectively. The cytotoxic effect of riluzole (250 microM) was unaltered by pre-chelating cytosolic Ca2+ with BAPTA. Collectively, in MDCK cells, riluzole rapidly increased [Ca2+]i by stimulating extracellular Ca2+ influx via an La3+ -sensitive pathway and intracellular Ca2+ release from the ER via, as yet, unidentified mechanisms. Furthermore, riluzole caused Ca2+ -unrelated cytotoxicity in a concentration-dependent manner.
机译:利鲁唑是用于治疗肌萎缩性侧索硬化症的药物;但是,其体外作用尚不清楚。在这项研究中,使用Ca2 +敏感荧光染料fura-2,研究了利鲁唑对Madin-Darby犬肾(MDCK)细胞中细胞内Ca2 +浓度([Ca2 +] i)的影响。利鲁唑(100-500 microM)以浓度依赖的方式(EC50 = 150 microM)导致[Ca2 +] i的持续快速增加。 [Ca2 +] i的这种增加的约40%和50%分别通过去除细胞外Ca2 +和添加La3 +来防止,但由二氢吡啶,维拉帕米和地尔硫卓则保持不变。在无Ca2 +的培养基中,毒胡萝卜素-内质网(ER)Caz + -ATPase的抑制剂-导致单相[Ca2 +] i增加,此后利鲁唑对[Ca2 +] i的增加作用减弱了70%;另外,用利鲁唑进行的预处理消除了thapsigargin诱导的[Ca2 +] i的增加。磷脂酶C(PLC)的抑制剂U73122废除了ATP(但不是利鲁唑)引起的[Ca2 +] i升高。在250和500 microM的浓度下,利鲁唑分别杀死40%和95%的细胞。利鲁唑(250 microM)的细胞毒作用通过用BAPTA预先螯合胞质Ca2 +并没有改变。总体而言,在MDCK细胞中,利鲁唑通过刺激La3 +敏感途径刺激细胞外Ca2 +流入而迅速增加[Ca2 +] i,并通过尚未确定的机制从ER释放细胞内Ca2 +。此外,利鲁唑以浓度依赖性方式引起Ca 2+-无关的细胞毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号